Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in EBS — Emergent BioSolutions Inc.

CIK 1137774 NEWARK, NJ
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$6,753,400
+$3,028,236 QoQ
Shares Held
805,895
+79.6% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names. EBS ranks #10 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 178,605 $30,102,086
2 ZTS
Zoetis Inc.
 200,280 $14,392,120
3 VTRS
Viatris Inc
 849,694 $13,493,139
4 INDV
Indivior Pharmaceuticals, Inc.
 262,336 $10,763,646
5 ELAN
Elanco Animal Health Inc
 424,167 $10,438,749
6 PBH
Prestige Consumer Healthcare Inc.
 216,865 $10,251,208
7 LQDA
Liquidia Corp
 122,836 $9,793,714
8 UTHR
UNITED THERAPEUTICS Corp
 16,798 $9,101,659

All Filings in EBS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,753,400 805,895
2026-03-31 $3,725,164 448,815
2025-12-31 $1,111,596 89,935
2025-09-30 $1,218,483 138,150
2025-03-31 $56,862 11,700
2024-12-31 $111,852 11,700
2024-09-30 $97,695 11,700
2024-06-30 $94,798 13,900
2024-03-31 $720,569 284,810
2023-12-31 $440,184 183,410
2023-09-30 $234,634 69,010
2023-06-30 $1,367,386 186,039
2023-03-31 $1,091,912 105,397
2022-12-31 $5,443,653 460,936
2022-09-30 $7,291,336 347,372
2022-06-30 $5,939,037 191,335
2022-03-31 $6,713,596 163,507
2021-12-31 $10,813,813 248,765
2021-09-30 $12,807,004 255,782
2021-06-30 $23,246,269 369,047
2021-03-31 $26,141,436 281,363
2020-12-31 $33,675,979 375,848
2020-09-30 $126,579 1,225
2020-06-30 $65,399 827
2020-03-31 $41,312 714